EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semisupervised adaptive learning models for IDH1 mutation status prediction

Fengning Liang, Yaru Cao, Teng Zhao, Qian Xu, Hong Zhu iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0321404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Fengning Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Glioma, Mutation, Deep Learning. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project for Research on Medical in Jiangsu Commission of Health, Xuzhou Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mutation status of isocitrate dehydrogenase1 (IDH1) in glioma is critical information for the diagnosis, treatment, and prognosis. Accurately determining such information from MRI data has emerged as a significant research challenge in recent years. Existing techniques for this problem often suffer from various limitations, such as the data waste and instability issues. To address such issues, we present a semisupervised adaptive deep learning model based on radiomics and rough sets for predicting the mutation status of IDH1 from MRI data. Firstly, our model uses a rough set algorithm to remove the redundant medical image features extracted by radiomics, while adding pseudo-labels for non-labeled data via statistical. T-tests to mitigate the common issue of insufficient datasets in medical imaging analysis. Then, it applies a Sand Cat Swarm Optimization (SCSO) algorithm to optimize the weight of pseudo-label data. Finally, our model adopts U-Net and CRNN to construct UCNet, a semisupervised classification model for classifying IDH1 mutation status. To validate our models, we use a preoperative MRI dataset with 316 glioma patients to evaluate the performance. Our study suggests that the prediction accuracy of glioma IDH1 mutation status reaches 95.63%. Our experimental results suggest that the study can effectively improve the utilization of glioma imaging data and the accuracy of intelligent diagnosis of glioma IDH1 mutation status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isocitrate DehydrogenaseGliomaMutationDeep LearningBrain NeoplasmsHumansMagnetic Resonance ImagingAlgorithms

Substanzen

Isocitrate DehydrogenaseIDH1 protein, human

Autor:innen und Institutionen

  • School of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Department of Computer Science and Engineering, State University of New York at Buffalo, Buffalo, New York, United States of America.

ORCID-Profile: Hong Zhu

Förderung

  • National Natural Science Foundation of China
  • Project for Research on Medical in Jiangsu Commission of Health
  • Xuzhou Key Research and Development Program

Zitieren

APA

Liang, F., Cao, Y., Zhao, T., Xu, Q., & Zhu, H. (2025). Semisupervised adaptive learning models for IDH1 mutation status prediction. PLOS One. https://doi.org/10.1371/journal.pone.0321404

Vancouver

Liang F, Cao Y, Zhao T, Xu Q, Zhu H. Semisupervised adaptive learning models for IDH1 mutation status prediction. PLOS One. 2025. doi:10.1371/journal.pone.0321404

BibTeX
@article{Liang2025,
  author = {Liang, Fengning and Cao, Yaru and Zhao, Teng and Xu, Qian and Zhu, Hong},
  title = {Semisupervised adaptive learning models for IDH1 mutation status prediction},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321404}
}
Kostenlos starten →